https://www.selleckchem.com/pr....oducts/bms-986205.ht
This review will outline the development of all the sensors used for rate adaptive pacing. The Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event (TRANSITION) and PIONEER-HF trials have shown that sacubitril/valsartan can be initiated early and safely in patients with heart failure with reduced ejection fraction (HFrEF) shortly after an acute heart failure episode during hospitalisation. However, it is unclear whether the results can be translated to Asian populati
Beğen
Yorum Yap
Paylaş
